Initiative Suggests Angiosarcoma Therapies

    Cancer Discovery
    |March 4, 2020
    PubMed

    Insights

    Researchers uncovered molecular details of angiosarcoma, revealing potential therapeutic targets. Patient participation in research models can overcome challenges in studying rare diseases like angiosarcoma.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Rare Diseases Research

    Background:

    • Angiosarcoma is a rare and aggressive cancer with limited treatment options.
    • Understanding the molecular basis of angiosarcoma is crucial for developing targeted therapies.

    Discussion:

    • The Angiosarcoma Project has shed light on the molecular mechanisms driving angiosarcoma.
    • This research identifies potential therapeutic avenues for angiosarcoma patients.

    Key Insights:

    • Molecular underpinnings of angiosarcoma have been elucidated.
    • Direct patient participation in research models proves effective for rare disease studies.

    Outlook:

    • Findings may lead to novel therapeutic strategies for angiosarcoma.
    • The patient-centric research model can accelerate rare cancer research.

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    8.6K
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    9.7K
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.6K